Surgery and adjuvant chemotherapy

International Journal of Clinical Oncology

Volumn 13, Issue 3, 2008, Pages 193-195

  Sasako, Mitsuru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adjuvant chemotherapy; D2 dissection; Gastric cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; UFT;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DRUG MEGADOSE; GASTRECTOMY; HUMAN; LYMPHADENECTOMY; MONOTHERAPY; MORBIDITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; UNSPECIFIED SIDE EFFECT;

CHEMOTHERAPY, ADJUVANT; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; STOMACH NEOPLASMS;

EID: 45749109401     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0791-1     Document Type: Review

References (22)

1. Sasako M (2004) Role of surgery in multidisciplinary treatment for solid cancers. Int J Clin Oncol 9:346-351
2. Fielding J (1989) Gastric cancer: different diseases. Br J Surg 76:1227
3. Macdonald JS, Smalley SR, Benedetti J, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730
4. Bonenkamp JJ, Hermans J, Sasako M, et al. (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908-914
5. Cuschieri A, Weeden S, Fielding J, et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79(9-10):1522-1530
6. Brennan MF (1999) Lymph-node dissection for gastric cancer. N Engl J Med 340:956-957
7. Sasako M, Saka M, Fukagawa T, et al. (2007) Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg 24:101-107
8. Wu CW, Hsiung CA, Lo SS, et al. (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309-315
9. Sasako M, Sano T, Yamamoto S, et al. (2006) Randomized phase III trial of standard D2 versus D2 + Para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501. Presented at 2006 ASCO Annual Meeting, Atlanta, GA, June 2-6, 2006 (abstract)
10. Cunningham D, Allum WH, Stenning SP, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
11. Neri B, Andreoli F, Boffi B, et al. (2001) Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow up. Br J Cancer 84:878-880
12. Bajetta E, Buzzoni R, Mariani L, et al. (2002) Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol 13:299-307
13. Chipponi J, Hugier M, Pezet D, et al. (2004) Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am J Surg 187:440-445
14. Bouché O, Ychou M, Burtin P, et al. (2005) Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol 16:1488-1497
15. Nitti D, Wils J, Dos Santos JG, et al. (2006) Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol 17:262-269
16. De Vita F, Giuliani F, Orditura M, et al. (2007) Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Ann Oncol 18:1354-1358
17. Nakajima T, Nashimoto A, Kitamura M, et al. (1999) Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial. Lancet 354:273-277
18. Nashimoto A, Nakajima T, Furukawa H, et al. (2003) Randomized trial of adjuvant chemotherapy with mitimycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21:2282-2287
19. Miyashiro I, Furukawa H, Sasako M, et al. (2005) No survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer: randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer. Presented at the 2005 Gastrointestinal Cancers Symposium, Hollywood, FL, January 27-29, 2005 (abstract)
20. Nakajima T, Kinoshita T, Nashimoto A, et al. (2007) Randomized controlled study of adjuvant uracil-tegaful versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg 94:1468-1476
21. Sakuramoto S, Sasako M, Yamaguchi T, et al. (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810-1820
22. Kim SK, Lim DH, Lee JY, et al. (2005) An observational study suggesting clinical benefit for adjuvant postoperative chemoradiotherapy in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol 63:1279-1285